CymaBay Therapeutics, Inc.

PNC FINANCIAL SERVICES GROUP, INC.

Report date

12/31/2023

Quarter

2023 Q4

Filed

3/22/2024

Shares

8,179

Value ($000)

193

Weight

0.0%

2019 Q4 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	3/22/2024	193	0.0%	8,179	12/31/2023
2023 Q3	11/13/2023	6	0.0%	423	9/30/2023
2022 Q1	5/12/2022	2	0.0%	442	3/31/2022
2021 Q4	2/11/2022	2	0.0%	442	12/31/2021
2021 Q3	11/5/2021	2	0.0%	442	9/30/2021
2021 Q2	8/6/2021	2	0.0%	442	6/30/2021
2021 Q1	5/7/2021	2	0.0%	442	3/31/2021
2020 Q4	2/12/2021	2	0.0%	442	12/31/2020
2020 Q3	11/6/2020	4	0.0%	442	9/30/2020
2020 Q2	8/28/2020	2	0.0%	442	6/30/2020
2020 Q1	5/8/2020	0	0.0%	442	3/31/2020
2019 Q4	2/7/2020	2	0.0%	564	12/31/2019